BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29370938)

  • 1. Na
    Yang Y; Mis MA; Estacion M; Dib-Hajj SD; Waxman SG
    Trends Pharmacol Sci; 2018 Mar; 39(3):258-275. PubMed ID: 29370938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No gain, no pain: NaV1.7 as an analgesic target.
    King GF; Vetter I
    ACS Chem Neurosci; 2014 Sep; 5(9):749-51. PubMed ID: 25111714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Na(V)1.7 pain control: a novel target.
    Hayes SB; Wang MY
    Neurosurgery; 2013 Dec; 73(6):N16. PubMed ID: 24257339
    [No Abstract]   [Full Text] [Related]  

  • 4. Insensitivity to Pain upon Adult-Onset Deletion of Nav1.7 or Its Blockade with Selective Inhibitors.
    Shields SD; Deng L; Reese RM; Dourado M; Tao J; Foreman O; Chang JH; Hackos DH
    J Neurosci; 2018 Nov; 38(47):10180-10201. PubMed ID: 30301756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief.
    Emery EC; Luiz AP; Wood JN
    Expert Opin Ther Targets; 2016 Aug; 20(8):975-83. PubMed ID: 26941184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voltage-gated sodium channels and pain pathways.
    Wood JN; Boorman JP; Okuse K; Baker MD
    J Neurobiol; 2004 Oct; 61(1):55-71. PubMed ID: 15362153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput electrophysiological assays for voltage gated ion channels using SyncroPatch 768PE.
    Li T; Lu G; Chiang EY; Chernov-Rogan T; Grogan JL; Chen J
    PLoS One; 2017; 12(7):e0180154. PubMed ID: 28683073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Na(V)1.7 sodium channel: from molecule to man.
    Dib-Hajj SD; Yang Y; Black JA; Waxman SG
    Nat Rev Neurosci; 2013 Jan; 14(1):49-62. PubMed ID: 23232607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomic Dysfunction Linked to Inhibition of the Na
    Regan CP; Morissette P; Kraus RL; Wang E; Arrington L; Vavrek M; de Hoon J; Depre M; Lodeweyck T; Demeyer I; Laethem T; Stoch A; Struyk A
    Circulation; 2024 Apr; 149(17):1394-1396. PubMed ID: 38648272
    [No Abstract]   [Full Text] [Related]  

  • 10. Painful Na-channelopathies: an expanding universe.
    Waxman SG
    Trends Mol Med; 2013 Jul; 19(7):406-9. PubMed ID: 23664154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium channels and pain.
    Habib AM; Wood JN; Cox JJ
    Handb Exp Pharmacol; 2015; 227():39-56. PubMed ID: 25846613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational Model Systems for Complex Sodium Channel Pathophysiology in Pain.
    Schrenk-Siemens K; Rösseler C; Lampert A
    Handb Exp Pharmacol; 2018; 246():355-369. PubMed ID: 29374838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting voltage-gated sodium channels for pain therapy.
    Clare JJ
    Expert Opin Investig Drugs; 2010 Jan; 19(1):45-62. PubMed ID: 20001554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endocannabinoid anandamide inhibits voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 in Xenopus oocytes.
    Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Sata T
    Anesth Analg; 2014 Mar; 118(3):554-62. PubMed ID: 24557103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse pharmacogenomics: carbamazepine normalizes activation and attenuates thermal hyperexcitability of sensory neurons due to Na
    Yang Y; Adi T; Effraim PR; Chen L; Dib-Hajj SD; Waxman SG
    Br J Pharmacol; 2018 Jun; 175(12):2261-2271. PubMed ID: 28658526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pain and analgesia : Mutations of voltage-gated sodium channels].
    Eberhardt MJ; Leffler A
    Schmerz; 2017 Feb; 31(1):14-22. PubMed ID: 27402262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future potential and status of selective sodium channel blockers for the treatment of pain.
    Priest BT
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):682-92. PubMed ID: 19736626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
    Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M
    Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzonatate inhibition of voltage-gated sodium currents.
    Evans MS; Maglinger GB; Fletcher AM; Johnson SR
    Neuropharmacology; 2016 Feb; 101():179-87. PubMed ID: 26386152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressants inhibit Na
    Horishita T; Yanagihara N; Ueno S; Okura D; Horishita R; Minami T; Ogata Y; Sudo Y; Uezono Y; Sata T; Kawasaki T
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1255-1270. PubMed ID: 28905186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.